PharmaCyte Biotech Announces IND Submitted to U.S. FDA for Clinical Trial in Locally Advanced, Inoperable Pancreatic Cancer

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- #INDstatus--PharmaCyte Biotech announces its IND submission to the FDA for its clinical trial in locally advanced, inoperable pancreatic cancer.

Click to view original post